Evidence map›Paper›PMID 38496906›Full record

ArticleHeliyon2024

Protective effect of

Chunyu Chen, Xiaoxing Liu, Yingying Lin, Li Li, Miaomiao Guo, Fan Yi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Modulation of Aging Diseases via RAGE Targets: A Dietary Intervention Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chunyu ChenBeijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, PR China.
Xiaoxing LiuBeijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, PR China.
Yingying LinBeijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, PR China.
Li LiBeijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, PR China.
Miaomiao GuoBeijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, PR China.
Fan YiBeijing Key Laboratory of Plant Resources Research and Development, Beijing Technology and Business University, No. 11, Fucheng Road, Haidian District, Beijing, 100048, PR China.
Beijing Technology and Business University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The nonenzymatic glycation of fibroblasts causes functional downregulation and behavioral disorders in the skin. Methods: To investigate the effect of Results: IOP is a polysaccharide with a molecular weight (Mw) of 2.396 × 10 Conclusion: IOP effectively reduced the levels of inflammatory factors and reactive oxygen species produced by AGEs, further preventing the impairment of cell behavior (decreased migration and reduced cell adhesion) and preventing the downregulation of the expression of key extracellular matrix proteins induced by AGEs. The results indicate the potential application of IOP as an AGE inhibitor in skin care.

Indexed as

AGEsCMLInonotus obliquus polysaccharideNonenzymatic glycationSkin behavior disorder

Identifiers

PMID38496906
PMCPMC10944218
OpenAlexW4392578446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.